Search Results

WZ8040 10mg 10mg  | Purity Not Available

Adooq Bioscience

WZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.

More Information Supplier Page

WZ4002 50mg 50mg  | Purity Not Available

Adooq Bioscience

WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.

More Information Supplier Page

WZ4002 200mg 200mg  | Purity Not Available

Adooq Bioscience

WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.

More Information Supplier Page

XAV 939 100mg 100mg  | Purity Not Available

Adooq Bioscience

XAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).

More Information Supplier Page

XL184 free base 100mg 100mg  | Purity Not Available

Adooq Bioscience

XL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.

More Information Supplier Page

XL184 free base 10mg 10mg  | Purity Not Available

Adooq Bioscience

XL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.

More Information Supplier Page

XL147 50mg 50mg  | Purity Not Available

Adooq Bioscience

XL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.

More Information Supplier Page

XL147 25mg 25mg  | Purity Not Available

Adooq Bioscience

XL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.

More Information Supplier Page